OLMA Olema Pharmaceuticals, Inc.
Healthcare$13.55-0.95%ClosedMarket Cap: $1.18B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$41.88
Target (Median)
$41.50
Target Range
$35.00 - $48.00
Upside from current price: 209.1%
Rating Distribution
2 Strong Buy10 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Guggenheim | maintain | Buy | Buy |
| 2026-03-18 | Goldman Sachs | maintain | Buy | Buy |
| 2026-03-18 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-17 | Guggenheim | maintain | Buy | Buy |
| 2026-03-17 | Citigroup | maintain | Buy | Buy |
| 2026-03-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-12 | Citigroup | maintain | Buy | Buy |
| 2025-12-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-11 | Goldman Sachs | maintain | Buy | Buy |
| 2025-12-11 | Oppenheimer | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.32 | $32.8M | 8 |
| Sun Dec 31 | $-1.85 | $132.4M | 4 |
| Mon Dec 31 | $-1.09 | $294.8M | 2 |
| Tue Dec 31 | $0.35 | $536.6M | 2 |